Lupin

Southern Cross Pharma is a privately owned company providing pharmaceutical products to the Australian and New Zealand markets.

Symbiomix is a late-stage, privately-held biopharmaceutical company developing innovative medicines for serious women’s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world’s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences, and HBM Partners. The Company’s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next-generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.

The Temmler Group, with its 7 production sites in Europe, is one of the largest providers of contract services in the pharmaceutical environment. Temmler has a wide experience in formulation development of finished solid, semi-solid and liquid dosage forms, in manufacture, packaging, blinding, distribution and return handling of clinical trial supplies, in the optimization of established manufacturing processes as well as in the contract manufacture of medicinal products with marketing authorization, supplemented by Quality Control and Analytical services. Temmler offers services from stand-alone processes according to customer specifications, to strategic services comprising the entire supply chain.

GAVIS Pharmaceuticals, LLC is a niche drug product sales and distribution company.

Novel Laboratories, Inc., a pharmaceutical company, engages in the research, development, and manufacture of generic and branded products in a range of therapeutic classes and dosage forms. Its product portfolio comprises immediate and modified release tablets; capsules and powders; liquids, such as solutions and suspensions; topical products, including gels, lotions, foams, ointments, and creams; respiratory products; vaginal and rectal suppositories; otic products, including solutions and suspensions; injectables, such as lyophilized powder and solutions in vials, ampules, and large volume parenterals; and ophthalmic solutions and suspensions droppers.

JSC Biocom manufactures reproduced pharmaceutical (generic) products in tablet and capsule forms. The company offers agents that affect the hemopoietic system and blood, cardio-vascular system, alimentary system, nervous system, and musculoskeletal system, as well as dermatological and antimicrobial agents. It also offers pharmaceuticalcontract manufacturing services.

Medquímica Indústria Farmacêutica S.A. operates as a pharmaceutical company. The company develops solid and liquid drugs that include over-the-counter, cardio, farma, gastro, hospital, generic, herbal, and dietary supplement products. It serves customers through representatives in Brazil.

Pharma Dynamics (Pty) Ltd. operates as a pharmaceutical company. The company offers generic pharmaceuticals; cardiovascular products; central nervous system, pediatric, and over-the-counter products for cold and flu, allergy, heartburn, and immune booster categories; and critical hospital products, such as antibiotics, and male and female specialty healthcare portfolios.

Laboratorios Grin is a pharmaceutical company that manufactures ophthalmological products, antivertiginosis, and oral antibiotics products.